Keith Speights

Keith Speights


Keith began writing for the Fool in 2012 and focuses primarily on healthcare investing topics. His background includes serving in management and consulting for the healthcare technology, health insurance, medical device, and pharmacy benefits management industries.

Recent articles

Bipolar disorder

Why Intra-Cellular Therapies Stock Is Skyrocketing Today

Investors are reacting enthusiastically to the company's latest clinical results.

COVID-19 vaccine and $100 bills

Why Inovio Pharmaceuticals Stock Is Jumping Today

Two developments could improve the biotech's prospects of receiving federal funding for its coronavirus vaccine program.

Patient getting a shot

Should Investors Worry About Moderna Slowing Enrollment in Its Coronavirus Vaccine Trial?

The short answer: No.

Pushing frown face icon

What to Like -- and Loathe -- About Aurora Cannabis' Latest Update

The Canadian cannabis producer gave investors some good news, but there was even more bad news.

Woman with light bulbs

3 Undeniably Brilliant Robinhood Stocks to Buy Right Now Even if the Market Crashes

They're popular on Robinhood and poised to win regardless of what happens with the stock market.

Clear dental aligner

Why SmileDirectClub Stock Jumped Today

Two positive developments boosted enthusiasm about the company's prospects.


Why Co-Diagnostics Stock Is Skyrocketing Today

Good news could be fueling a short squeeze.

Woman holding question mark in front of face

Should You Invest in Coronavirus ETFs?

There are advantages -- and disadvantages -- to some of the newest ETFs on the market.

Warren Buffett (TMF photo)

3 Robinhood Stocks That Warren Buffett Absolutely Loves

Should you love them too?

Hand pointing to light bulb with dollar sign

The 1 Stock I'd Buy Right Now

Even the negatives for this stock aren't all that bad.

COVID-19 vaccine bottles over $100 bills

How to Invest in Coronavirus Vaccine Stocks

Just follow these three simple steps.

Cannabis leaf on top of Ben Franklin on $100 bill

3 Top Marijuana Stocks to Buy in September

These cannabis stocks have at least two things in common: A focus on the U.S. market and tremendous growth.

Doctor holding stethoscope to healthcare icons

Why DexCom, Livongo Health, and Teladoc Health Stocks Are Tumbling Today

Blame it on the overall stock market.

Scientist with syringe and vaccine bottle

Why Novavax Stock Is Sinking Today

The overall market sell-off is dragging down the biotech.

Dollar sign and light bulb

Got $3,000? Buying These 3 Stocks Could Make You Rich

All you have to do is buy -- and wait.

COVID-19 vaccine syringe and U.S.

3 Drugmakers Most Likely to Launch Coronavirus Vaccines in the U.S. by the End of 2020

Yes, one or more COVID-19 vaccines could realistically be available before the end of the year.

Scientist looking through microscope

Why Sunesis Pharmaceuticals Stock Is Sinking Today

The drugmaker is having to take a last-resort measure to keep its shares listed on the Nasdaq stock exchange.

Man looking at line chart going through floor

Why Akebia Therapeutics Stock Is Crashing Today

The company's lead pipeline candidate fell short in a late-stage clinical study.

U.S. Capitol building

Don't Buy Pot Stocks Just Because the U.S. House Will Vote on Legalizing Marijuana This Month

This marijuana milestone will probably be an exercise in futility.

Short selling sign

3 Heavily Shorted Coronavirus Vaccine Stocks

Short-sellers are betting against these stocks big time. But that could set up big opportunities for investors if these biotechs have positive news on the way.